- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | VITURA HEALTH LIMITED: FY26 Results Investor Webinar | - | ASX | ||
| 27.07. | VITURA HEALTH LIMITED: Notification of cessation of securities - VIT | 1 | ASX | ||
| 22.07. | VITURA HEALTH LIMITED: Vitura announces new senior appointments | - | ASX | ||
| 09.07. | VITURA HEALTH LIMITED: Change of Address | - | ASX | ||
| 05.06. | VITURA HEALTH LIMITED: Appointment of Interim Chief Financial Officer | - | ASX | ||
| VITURA HEALTH Aktie jetzt für 0€ handeln | |||||
| 05.06. | VITURA HEALTH LIMITED: Change of Director's Interest Notice | - | ASX | ||
| 03.06. | VITURA HEALTH LIMITED: Chief Financial Officer Resignation | - | ASX | ||
| 27.05. | VITURA HEALTH LIMITED: Ceasing to be a substantial holder | - | ASX | ||
| 27.05. | VITURA HEALTH LIMITED: Change in substantial holding | - | ASX | ||
| 20.05. | VITURA HEALTH LIMITED: Former CEO Legal Action Initiated | - | ASX | ||
| 28.04. | VITURA HEALTH LIMITED: Business Transformation Update | - | ASX | ||
| 21.04. | Vitura Health's Doctors on Demand on Track for Sustained Profitability as Consultations Surpass 1 Million | 1 | smallcaps.com.au | ||
| 21.04. | VITURA HEALTH LIMITED: Doctors on Demand Performance Update | - | ASX | ||
| 07.04. | VITURA HEALTH LIMITED: Final Director's Interest Notice | - | ASX | ||
| 07.04. | VITURA HEALTH LIMITED: Resignation of Non-Executive Director | - | ASX | ||
| 02.04. | VITURA HEALTH LIMITED: Appointment of Chief Executive Officer | - | ASX | ||
| 29.03. | VITURA HEALTH LIMITED: Notification of cessation of securities - VIT | - | ASX | ||
| 22.03. | VITURA HEALTH LIMITED: Cortexa advances commercialisation of MDMA supply | - | ASX | ||
| 17.03. | Vitura Health Signs Online Distribution Deal for MedReleaf Medicinal Cannabis Products | 2 | smallcaps.com.au | ||
| 17.03. | VITURA HEALTH LIMITED: VIT enters distribution agreement with MedReleaf Australia | - | ASX |
1 2 Weiter >>
26 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| AURORA CANNABIS | 3,366 | -0,24 % | Curaleaf Holdings, Inc.: Curaleaf Launches Take-Over Bid to Acquire Aurora Cannabis, Invites Aurora Shareholders to Tender to the Bid | Formal offer and take-over bid circular filed and will be delivered to Aurora shareholders
Offer provides total implied consideration of US$4.00 per share, representing... ► Artikel lesen | |
| TILRAY BRANDS | 4,185 | +1,21 % | Tilray Brands, Inc.: Tilray Medical begrüßt die positiven Entwicklungen im deutschen Rechtsrahmen für medizinisches Cannabis und setzt sich für dessen kontinuierliche Weiterentwicklung ein | Als weltweit führender Anbieter von medizinischem Cannabis unterstützt Tilray Medical eine Weiterentwicklung der Regulierung, die das Vertrauen der Ärzteschaft stärkt, den Zugang der Patienten schützt... ► Artikel lesen | |
| ORGANIGRAM GLOBAL | 1,028 | -3,56 % | Organigram Global Inc.: Organigram Global treibt die Integration der Sanity Group unter einer einheitlichen globalen Betriebsstruktur voran | Führung, operatives Geschäft und Marktentwicklung werden über eine globale Plattform aufeinander abgestimmt, die Kanada mit Deutschland und anderen wichtigen internationalen Märkten verbindet
Die... ► Artikel lesen | |
| SNDL | 1,139 | -3,31 % | Immortal Dragons: Sundial Initiative Advisor Boyang Wang Sponsors Nakauchi Lab's Work on "Bodyoids" | SINGAPORE, SG / ACCESS Newswire / July 30, 2026 / Boyang Wang, advisor to the Sundial Initiative and founder and CEO of the longevity fund Immortal Dragons, has sponsored the Nakauchi Lab, led by stem... ► Artikel lesen | |
| NOVERIS HEALTH SCIENCES | 0,127 | +38,80 % | Noveris Health Sciences Inc.: Noveris Health Sciences Announces Proposed Private Placement of Convertible Debentures for up to $500,000 | Vancouver, British Columbia--(Newsfile Corp. - August 20, 2026) - Noveris Health Sciences Inc. (CSE: NVRS) (FSE: 0NF1) (OTC Pink: MYCOF) (the "Company" or "Noveris") is pleased to announce its intention... ► Artikel lesen | |
| BIONANO GENOMICS | 1,195 | -0,42 % | Bionano Genomics: Bionano Announces Hiring of Chief Scientific Officer | SAN DIEGO, June 24, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO), a leader in genome analysis solutions, today announced the appointment of Alex Hastie, Ph.D., as its Chief Scientific... ► Artikel lesen | |
| TONIX PHARMACEUTICALS | 10,900 | +1,44 % | Tonix Pharmaceuticals Holding Corp. - 8-K, Current Report | ||
| HIGH TIDE | 2,085 | -0,95 % | High Tide Inc.: High Tide Announces Voting Results of Annual General and Special Meeting of Shareholders | CALGARY, AB, Aug. 12, 2026 /PRNewswire/ -- High Tide Inc. ("High Tide" or the "Company") (Nasdaq: HITI) (TSXV: HITI) (FSE: 2LYA), the high-impact, retail-forward enterprise built to deliver... ► Artikel lesen | |
| ACHIEVE LIFE SCIENCES | 6,900 | +0,73 % | Achieve Life Sciences Reports Second Quarter 2026 Financial Results and Provides Business Updates | Closed a private placement of up to $354 million, with $180 million upfront and up to $174 million from warrants exercisable prior to and up to 20 trading days following FDA approval Strengthened... ► Artikel lesen | |
| JAGUAR HEALTH | 0,868 | 0,00 % | Jaguar Health, Inc.: Jaguar Health Reports Second Quarter 2026 Financials | Company remains sharply focused on its ongoing global development program for crofelemer for rare intestinal failure (IF) diseases; as announced, presentation at ESPGHAN 2026 described additional groundbreaking... ► Artikel lesen | |
| GREENRISE GLOBAL BRANDS | 0,005 | -100,00 % | CSE Bulletin: Suspensions - Adastra Holdings Ltd., CAT Strategic Metals Corporation, Greenrise Global Brands Inc., StickIt Technologies Inc. | Le 12 mai/May 2026
Effective immediately, the following companies are suspended pursuant to CSE Policy 3. The suspensions are considered Regulatory Halts as defined in National Instrument 23-101... ► Artikel lesen | |
| MEDIPHARM LABS | 0,046 | 0,00 % | Neues Label integriert zusätzliche Funktionen in Injektor-Plattform: Schreiner MediPharm hat ein multifunktionales ... | ||
| ARGENT BIOPHARMA | 0,014 | +3,85 % | ARGENT BIOPHARMA LIMITED: Proposed issue of securities - RGT | ||
| AYR WELLNESS | 0,050 | 0,00 % | Ayr Wellness Inc.: AYR Wellness Announces Closing of Exit Facility and Related Transactions | MIAMI, April 10, 2026 (GLOBE NEWSWIRE) -- AYR Wellness Inc. (CSE: AYR.A, OTCQX: AYRWF) ("AYR" or the "Company"), a leading vertically integrated U.S. multi-state cannabis operator, announces the initial... ► Artikel lesen |
Das Unternehmen VITURA HEALTH LIMITED kann der Branche Pharma zugeordnet werden. Mit einer aktuellen Kursveränderung von +0,001 (+5,88 %) liegt der Kurs bei 0,009 Euro. Beim derzeitigen Kurs ergibt sich, basierend auf einer gesamten Ausschüttung von 0,00 Euro in den vergangenen 12 Monaten, eine Dividendendrendite von 0,00 %.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu VITURA HEALTH LIMITED finden Sie auf Wallstreet Online.